Newsfeeds - Spark Newswire

2 minute read

Earnings

Fortress Biotech Earnings Perspective: Return On Capital Employed

Today, 8:05 AM

Benzinga Pro data, Fortress Biotech (NASDAQ:FBIO) reported Q2 sales of $18.89 million. Earnings fell to a loss of $53.93 million, resulting in a 9.0% decrease from last quarter.

FBIO

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 8:05 AM

ALNA

1 minute read

Earnings

Fortress Biotech: Q2 Earnings Insights

By Benzinga Insights

Today, 8:05 AM

Fortress Biotech (NASDAQ:FBIO) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

FBIO

1 minute read

Fortress Biotech Q2 EPS $(0.10) Up From $(0.17) YoY

By Bill Haddad

Today, 8:05 AM

Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.10) per share. This is a 41.18 percent increase over losses of $(0.17) per share from the same period last year.

FBIO

1 minute read

Analyst Ratings

B. Riley Securities Maintains Buy Rating for Fortress Biotech: Here’s What You Need To Know

By Benzinga Insights

Today, 8:05 AM

B. Riley Securities has decided to maintain its Buy rating of Fortress Biotech (NASDAQ:FBIO) and lower its price target from $8.00 to $6.00. Shares of Fortress Biotech are trading down 1.01% over the last 24 hours, at $0.87 per share.

FBIO

1 minute read

B. Riley Securities Maintains Buy on Fortress Biotech, Lowers Price Target to $6

By Benzinga Newsdesk

Today, 8:05 AM

B. Riley Securities analyst Mayank Mamtani maintains Fortress Biotech (NASDAQ:FBIO) with a Buy and lowers the price target from $8 to $6.

FBIO

44 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 8:05 AM

On Wednesday, 807 companies reached new 52-week lows.

AADI

44 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 8:05 AM

Wednesday's session saw 784 companies set new 52-week lows.

AADI

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 8:05 AM

Gainers

CYTH

2 minute read

Earnings

Looking Into Fortress Biotech’s Return On Capital Employed

By Benzinga Insights

Today, 8:05 AM

Benzinga Pro data, Fortress Biotech (NASDAQ:FBIO) reported Q4 sales of $18.28 million. Earnings fell to a loss of $68.51 million, resulting in a 49.38% decrease from last quarter.

FBIO